Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development.
暂无分享,去创建一个
Gavin Thurston | A. Murphy | G. Yancopoulos | N. Gale | G. Thurston | J. Holash | N. Adams | M. Dominguez | D. Valenzuela | George D Yancopoulos | Jocelyn Holash | Niels C Adams | Nicholas W Gale | Li Pan | Andrew J Murphy | David M Valenzuela | Hsin Chieh Lin | Melissa G Dominguez | Irene Noguera | Virginia Hughes | I. Noguera | V. Hughes | L. Pan | H. Lin | Virginia C. Hughes | Li Pan
[1] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[2] G. Yancopoulos,et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. , 2001, Developmental biology.
[3] I. Buschmann,et al. The pathophysiology of the collateral circulation (arteriogenesis) , 2000, The Journal of pathology.
[4] G Garcia-Cardena,et al. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. , 2001, Developmental biology.
[5] Manfred Gessler,et al. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. , 2004, Genes & development.
[6] J. Byrd,et al. Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers. , 2002, Seminars in oncology.
[7] G. Yancopoulos,et al. VEGF-Trap: A VEGF blocker with potent antitumor effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Gerety,et al. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. , 2002, Development.
[9] W. Richards,et al. Dll4, a novel Notch ligand expressed in arterial endothelium. , 2000, Genes & development.
[10] P. Campochiaro,et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.
[11] J. Sundberg,et al. Notch signaling is essential for vascular morphogenesis in mice. , 2000, Genes & development.
[12] Yan Li,et al. Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis , 2003, Molecular and Cellular Biology.
[13] A. F. Stewart,et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis , 2003, Nature Biotechnology.
[14] G. Weinmaster,et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. , 2001, Development.
[15] N. Gale,et al. Vascular Endothelial Growth Factor and Other Signaling Pathways in Developmental and Pathologic Angiogenesis , 2004, International journal of hematology.
[16] David J. Anderson,et al. Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.
[17] D. Anderson,et al. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.
[18] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[19] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[20] R Bicknell,et al. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. , 2001, Differentiation; research in biological diversity.
[21] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[22] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[23] Yi Wei,et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). , 2004, Genes & development.
[24] G. Weinmaster,et al. Notch1 is essential for postimplantation development in mice. , 1994, Genes & development.
[25] A. Fischer,et al. Hey genes in cardiovascular development. , 2003, Trends in cardiovascular medicine.
[26] J. Kitajewski,et al. Notch function in the vasculature: insights from zebrafish, mouse and man , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] Tasuku Honjo,et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. , 2004, Genes & development.
[28] Janet Rossant,et al. Dosage-sensitive requirement for mouse Dll4 in artery development. , 2004, Genes & development.